| Outcome Measures: |
Primary: Cmax of Dapagliflozin, Maximum plasma concentration of Dapagliflozin, 0 hour ~ 48 hour after drug administration|Cmax of Metformin, Maximum plasma concentration of Metformin, 0 hour ~ 48 hour after drug administration|AUClast of Dapagliflozin, Area under the plasma concentration-time curve to last concentration of Dapagliflozin, 0 hour ~ 48 hour after drug administration|AUClast of Metformin, Area under the plasma concentration-time curve to last concentration of Metformin, 0 hour ~ 48 hour after drug administration | Secondary: AUCinf of Dapagliflozin, Area under the plasma concentration-time curve from zero to infinity concentration of Dapagliflozin, 0 hour ~ 48 hour after drug administration|AUCinf of Metformin, Area under the plasma concentration-time curve from zero to infinity concentration of Metformin, 0 hour ~ 48 hour after drug administration|Tmax of Dapagliflozin, Time to maximum plasma concentration of Dapagliflozin, 0 hour ~ 48 hour after drug administration|Tmax of Metformin, Time to maximum plasma concentration of Metformin, 0 hour ~ 48 hour after drug administration|T1/2 of Dapagliflozin, Half-life of Dapagliflozin, 0 hour ~ 48 hour after drug administration|T1/2 of Metformin, Half-life of Metformin, 0 hour ~ 48 hour after drug administration|Vd/F of Dapagliflozin, Apparent volume of distribution of Dapagliflozin, 0 hour ~ 48 hour after drug administration|Vd/F of Metformin, Apparent volume of distribution of Metformin, 0 hour ~ 48 hour after drug administration|CL/F of Dapagliflozin, Apparent clearance of Dapagliflozin, 0 hour ~ 48 hour after drug administration|CL/F of Metformin, Apparent clearance of Metformin, 0 hour ~ 48 hour after drug administration
|
